Anti-Infectives Are Strategic For Sandoz
Committed To Tackling Antimicrobial Resistance
Sandoz’ Anti-Infectives business is not only commercially strategic, it is also a key factor in security of supply and combating antimicrobial resistance in Europe and beyond, Sandoz CEO Richard Saynor told Generics Bulletin.
